Soleno Therapeutics, Inc. · NASDAQ:SLNO

Avoro Capital Advisors LLC reported a 5.40% stake in Soleno Therapeutics, Inc. (Schedule 13G)

Event Dec 31, 2025 · Filed Feb 17, 2026

Avoro Capital Advisors LLC reported a 5.40% stake in Soleno Therapeutics, Inc., 2,900,000 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G).

Stake
5.40%
Shares
2,900,000
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Avoro Capital Advisors LLC5.40%2,900,000
Behzad Aghazadeh5.40%2,900,000

Source

View original at SEC

Related